Tempus AI
4.3Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue
Browse and compare the best Healthcare AI tools.
The best Healthcare AI tools right now are Tennr, Empaithy, and UnityAI. Tennr is our top overall pick (4.2/5). Compare all 8 below by price, features and rating to find the right fit.
| Tool | Best for | Free | From | Rating | Visit |
|---|---|---|---|---|---|
Tennr | Best overall | No | — | 4.2 | Visit |
Empaithy | Best value | No | — | 4.0 | Visit |
UnityAI | Also worth a look | No | — | 4.0 | Visit |
Zephyr AI | Most popular | No | — | 4.0 | Visit |
Sully.ai | Also worth a look | No | — | 4.0 | Visit |
Lila | Best free option | Yes | Free | 4.0 | Visit |
Passio | Also worth a look | No | — | 3.6 | Visit |
StressLess | Also worth a look | Yes | Free | 3.4 | Visit |
Abridge, Nabla, and Suki AI turn the patient conversation into structured notes so clinicians are not writing after hours. Documentation burden is one of the most consistently measured contributors to clinician burnout.
Viz.ai and Aidoc flag time-critical findings in scans so urgent cases move up the queue. In stroke and similar pathways, the value is measured in minutes to treatment.
OpenEvidence gives clinicians evidence-based answers with sources during the encounter rather than afterwards. It is used where the alternative is a literature search nobody has time for.
Health Harbor and Delfino AI place and navigate the insurance and payer calls that consume practice staff time. These target back-office cost rather than clinical decision-making.
These Healthcare AI tools offer a genuine free plan or trial, a smart place to start before you pay.
| Price tier | What you get | Examples |
|---|---|---|
| Free | $0, free plan or open-source | StressLess, Lila, Heidi, Gigasheet |
| Budget | Under $15/mo | Upheal |
| Mid-range | $15 to $39/mo | Intuition Robotics |
We verify every tool in this category is live and does what it claims, then score it on value, feature depth and how well it fits the job. Rankings are never for sale, and affiliate links never change a score. Read our full methodology
Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue
115 million patient interactions with zero safety incidents, and it still won't diagnose
FDA-cleared triage AI hitting 97% sensitivity, deployed in nearly 2,000 hospitals
Deployed at 300+ health systems, now backed by a strategic investment from Eli Lilly